These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15571173)

  • 21. Increasing antimicrobial resistance--an emerging problem in the treatment of shigellosis.
    Niyogi SK
    Clin Microbiol Infect; 2007 Dec; 13(12):1141-3. PubMed ID: 17953700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial.
    Khan WA; Seas C; Dhar U; Salam MA; Bennish ML
    Ann Intern Med; 1997 May; 126(9):697-703. PubMed ID: 9139555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [On the resistance of dysentery bacteria to antibiotics].
    Serebrainskiĭ VS
    Voen Med Zh; 1969 Feb; 2():45-7. PubMed ID: 5772336
    [No Abstract]   [Full Text] [Related]  

  • 24. Outbreak of Ciprofloxacin-Resistant Shigella sonnei Associated with Travel to Vietnam, Republic of Korea.
    Kim JS; Kim JJ; Kim SJ; Jeon SE; Seo KY; Choi JK; Kim NO; Hong S; Chung GT; Yoo CK; Kim YT; Cheun HI; Bae GR; Yeo YH; Ha GJ; Choi MS; Kang SJ; Kim J
    Emerg Infect Dis; 2015 Jul; 21(7):1247-50. PubMed ID: 26079171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of shigellosis in Lagos, Nigeria: trends in antimicrobial resistance.
    Iwalokun BA; Gbenle GO; Smith SI; Ogunledun A; Akinsinde KA; Omonigbehin EA
    J Health Popul Nutr; 2001 Sep; 19(3):183-90. PubMed ID: 11761772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multi-center randomized trial to assess the efficacy of gatifloxacin versus ciprofloxacin for the treatment of shigellosis in Vietnamese children.
    Vinh H; Anh VT; Anh ND; Campbell JI; Hoang NV; Nga TV; Nhu NT; Minh PV; Thuy CT; Duy PT; Phuong le T; Loan HT; Chinh MT; Thao NT; Tham NT; Mong BL; Bay PV; Day JN; Dolecek C; Lan NP; Diep TS; Farrar JJ; Chau NV; Wolbers M; Baker S
    PLoS Negl Trop Dis; 2011 Aug; 5(8):e1264. PubMed ID: 21829747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased susceptibility to antimicrobials among Shigella flexneri isolates in Manipal, South India--a 5 year hospital based study.
    Mamatha B; Rituparna C
    Southeast Asian J Trop Med Public Health; 2012 Nov; 43(6):1447-51. PubMed ID: 23413708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Considerations on dysentery caused by Shigella with multiple resistance to antibiotics].
    Brauner E; Cuciureanu G; Hurmuzache T; Turcu T; Grigoriu A; Cercel I
    Microbiol Parazitol Epidemiol (Bucur); 1969; 14(3):221-6. PubMed ID: 5344218
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical significance of determining the sensitivity of dysentery microbes to antibiotics].
    Bochorishvili VG; Gegiia TN; Bibineĭshvili MV; Giorgobiani ES; Ukleba KD
    Sov Med; 1972 May; 35(5):63-6. PubMed ID: 5042690
    [No Abstract]   [Full Text] [Related]  

  • 30. Emerging resistance to newer antimicrobial agents among Shigella isolated from Finnish foreign travellers.
    Haukka K; Siitonen A
    Epidemiol Infect; 2008 Apr; 136(4):476-82. PubMed ID: 17578602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacillary dysentery. An institutional outbreak of Shigella sonnei: treatment of 36 cases with nalidixic acid.
    Fernandez LA
    J Kans Med Soc; 1966 Jul; 67(7):359-60 passim. PubMed ID: 5330682
    [No Abstract]   [Full Text] [Related]  

  • 32. Emergence of ceftriaxone resistant Shigella.
    Goel N; Wattal C; Kaul D; Khanna VK
    Indian J Pediatr; 2013 Jan; 80(1):70-1. PubMed ID: 22205379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes in the degree of sensitivity to antibiotics of Shigella isolated from patients with dysentery in a city infectious disease hospital over the past 8 years].
    Givental' NI; Saparov OS; Bogdanova LF; Chekrygina ON; Vel'mina EA
    Antibiot Khimioter; 1988 Feb; 33(2):135-7. PubMed ID: 3288150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence of nalidixic acid resistance in Shigella sonnei isolated from patients having acute diarrheal disease: report from eastern province of Saudi Arabia.
    Panhotra BR; Saxena AK; Al-Mulhim K
    Jpn J Infect Dis; 2004 Jun; 57(3):116-8. PubMed ID: 15218222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial therapy for shigellosis: issues on antimicrobial resistance.
    Salam MA
    Jpn J Med Sci Biol; 1998; 51 Suppl():S43-62. PubMed ID: 10211436
    [No Abstract]   [Full Text] [Related]  

  • 36. Increasing incidence of antibiotic resistance in shigellas from humans in England and Wales: recommendations for therapy.
    Cheasty T; Skinner JA; Rowe B; Threlfall EJ
    Microb Drug Resist; 1998; 4(1):57-60. PubMed ID: 9533726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Death from multi-resistant shigelloses: a case study from Fiji.
    Watson C
    Pac Health Dialog; 2006 Sep; 13(2):111-4. PubMed ID: 18181399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiresistant Shigella species isolated from childhood diarrhea cases in Kolkata, India.
    Niyogi SK; Pazhani GP
    Jpn J Infect Dis; 2003 Feb; 56(1):33-4. PubMed ID: 12711826
    [No Abstract]   [Full Text] [Related]  

  • 39. Danger of antibiotic resistance in shigellosis.
    Kaya IS; Dilmen U; Senses DA
    Lancet; 1990 Jul; 336(8708):186. PubMed ID: 1973507
    [No Abstract]   [Full Text] [Related]  

  • 40. Shigella species epidemiology and antimicrobial susceptibility: the implications of emerging azithromycin resistance for guiding treatment, guidelines and breakpoints.
    Brown JD; Willcox SJ; Franklin N; Hazelton B; Howard P; Reinten T; Sheppeard V; O'Sullivan M
    J Antimicrob Chemother; 2017 Nov; 72(11):3181-3186. PubMed ID: 28961759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.